Minerva Neurosciences, Inc. (NERV)
2.36
+0.02
(+0.64%)
USD |
NASDAQ |
Nov 03, 16:00
2.36
0.00 (0.00%)
After-Hours: 18:25
Minerva Neurosciences Cash and Short Term Investments (Quarterly) : 75.37M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.37M |
| March 31, 2026 | 78.16M |
| December 31, 2025 | 82.40M |
| September 30, 2025 | 12.39M |
| June 30, 2025 | 15.35M |
| March 31, 2025 | 17.39M |
| December 31, 2024 | 21.46M |
| September 30, 2024 | 26.63M |
| June 30, 2024 | 30.98M |
| March 31, 2024 | 34.92M |
| December 31, 2023 | 41.01M |
| September 30, 2023 | 47.00M |
| June 30, 2023 | 51.90M |
| March 31, 2023 | 36.08M |
| December 31, 2022 | 36.19M |
| September 30, 2022 | 40.32M |
| June 30, 2022 | 49.85M |
| March 31, 2022 | 55.05M |
| December 31, 2021 | 60.86M |
| September 30, 2021 | 65.69M |
| June 30, 2021 | 74.31M |
| March 31, 2021 | 80.24M |
| December 31, 2020 | 25.46M |
| September 30, 2020 | 32.62M |
| June 30, 2020 | 35.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 37.61M |
| December 31, 2019 | 45.95M |
| September 30, 2019 | 60.03M |
| June 30, 2019 | 69.39M |
| March 31, 2019 | 79.26M |
| December 31, 2018 | 88.10M |
| September 30, 2018 | 97.71M |
| June 30, 2018 | 108.59M |
| March 31, 2018 | 121.10M |
| December 31, 2017 | 128.24M |
| September 30, 2017 | 133.01M |
| June 30, 2017 | 77.65M |
| March 31, 2017 | 85.44M |
| December 31, 2016 | 83.06M |
| September 30, 2016 | 91.93M |
| June 30, 2016 | 97.14M |
| March 31, 2016 | 44.72M |
| December 31, 2015 | 32.28M |
| September 30, 2015 | 37.57M |
| June 30, 2015 | 35.47M |
| March 31, 2015 | 52.24M |
| December 31, 2014 | 18.58M |
| September 30, 2014 | 23.64M |
| June 30, 2014 | 0.48M |
| March 31, 2014 | 2.141M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 42.66M |
| Tonix Pharmaceuticals Holding Corp. | 176.23M |
| Karyopharm Therapeutics, Inc. | 65.10M |
| Corbus Pharmaceuticals Holdings, Inc. | 117.94M |
| Ocugen, Inc. | 100.05M |